• UTAHMEDPROVIDERWEBITEIMAGE

Utah Qualified Medical Provider Certification

Rated 4.55 out of 5 based on 99 customer ratings
(99 customer reviews)

$75.00
4.55 out of 5

The Medical Marijuana 411 online curriculum is designed to educate physicians, physician assistants, pharmacists and nurse practitioners about medical marijuana based on research and unbiased content. The Utah Qualified Medical  Provider Certification course has been approved by the Utah Department of Health.  This course meets or exceeds the Utah DOH, Center for Medical Cannabis Qualified Medical Provider Continuing Education Requirement, of a minimum of 4 hours of CE to become a registered, qualified practitioner with the Utah Department of Health under Utah Code 26-61a-106 (3).

The curriculum for the Utah Medical Cannabis Qualified Medical Provider also allows physicians and physician assistants to claim up to 10 AMA PRA Category 1 ™ credits through the Medical Marijuana 411 ACCME accredited course. Pharmacists and Nurse Practitioners can claim up to 10 hours CPE and CNE credit (respectively) as the CME course is also accredited by the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).

The curriculum includes Utah State Medical Marijuana law. Developed as a curriculum that includes the AMA PRA Category 1 Credit(s)™ course and Utah State Medical Marijuana, only 1 certificate will need to be submitted to the Utah DOH for approval.

NOTE: The course also is accredited by the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).

If you are a medical group or network and need multi-seat pricing, please call 844.411.0500 x813.

Registration requirements and instructions are available online on the DOH website.

More information about the Utah Medical Cannabis Act and medical provider training is available at medicalcannabis.utah.gov or (801)538-6504.

SKU: d97ae1d3-6f26-4cd9-88d5-78b0a7f0d694 Categories: All Products, Utah, Certification Courses, CME Courses, Medical Education
  • Description
  • Reviews (99)
    4.55 out of 5
  • UTAHQMPBADGE-01-site-badge-300x250

    Program Overview

    The activity is an educational overview of medical cannabis in its current legal context in the US. Currently there are 2.1 million registered medical marijuana patients and there are an estimated 3.5 million patients using medical marijuana nationwide. The constantly changing legal environment in which cannabis can be used in the United States has resulted in confusion for both physicians and patients. Currently, 33 states have legalized medical marijuana and 10 states have also legalized recreational marijuana. Due to the lack of knowledge of the legality of discussing medical marijuana, physicians, nurses and pharmacists are hesitant to discuss with their patients. The lack of communication between the patient and physician can lead to the patient self-medicating with no guidance from a medical professional.

    • Program Agenda & Objectives
    • Physician Credit
    • What's Included
    • Faculty
    • Cited Experts
    • Utah Legal Overview

        • Utah Medical Cannabis Act
        • Qualifying Conditions
        • Applying for a medical cannabis card through their qualified medical provider (QMP)
        • Definition of QMP
        • Requirements to recommend medical cannabis
        • Participation in the Medical Cannabis Program
        • Four types of medical cannabis patient cards
      • Utah State Legal Statutes – Definitions and Provisions
      • Definition, differentiations and cultivation, processing, medical recommendation, and patient use of medical cannabis under the Utah Medical Cannabis Act
      • Differentiates between the cultivation, processing and production of cannabis as outlined in the Utah Medical Cannabis Act
      • Approved methodologies and dosage for medical cannabis
        • Approved forms of cannabis; ways to medicate
        • Changes from 9.16.19 Special Legislative Session – allows for patients to receive a standard 30-day supply of medical cannabis, regardless of their distance to a Medical Cannabis Pharmacy.
      • Licensing and Regulation – Medical Providers and Cannabis Pharmacies
        • Qualifying Medical Provider (QMP)
          • Requirements
          • Registration
          • Patient Limitations
            • Exceptions – Hospice and Palliative Care
            • Petition for more clients
          • Electronic Documentation Requirements
          • Patient Counseling Requirements
          • Medical Cannabis Pharmacies
            • Overview and age requirements
            • Changes from 9.16.19 Special Legislative Session
            • State Central Fill Pharmacy and Local Health Department – REMOVED
            • Increase of Medical Cannabis Pharmacies from seven to fourteen
            • Home Delivery
            • State Central Patient Portal
          • Packaging, Labeling and Tracking Requirements
            • What must be on medical cannabis labels
            • Transaction database requirements

      After completing this activity, the participant should be better able to:

      • Interpret the Federal and Utah legal context regarding medical marijuana even though marijuana is recognized as a federally illegal substance. NOTE: Utah Legal section includes the updates from the 9.16.19 Special Legislative Session which includes no mention of the State Central Fill Pharmacy and Local Health Department within the coursework, State Central Patient Portal, number of medical cannabis pharmacies increased from seven to fourteenand amended rules for standard 30 day supply of medical cannabis, regardless of distance to a medical marijuana pharmacy.
      • Explain why there is a lack of clinical studies due to Schedule I classification of marijuana.
      • Utah Medical Cannabis Act and other Utah state laws relating to medical cannabis.
      • Summarize and explain the Pharmacology of Marijuana including the discovery of the Endocannabinoid System and how its discovery has led to further research into how cannabinoids interact with the receptors.
      • Summarize the function of the Endocannabinoid System in the regulation of the body through a vast network of receptors involved in maintaining homeostasis, neuroprotection, and other regulatory functions.
      • Understand the History of Cannabis, prohibition and early use
      • Discuss and interpret the basic pharmacology of phytocannabinoids, major and minor cannabinoids, terpenes and the effect on the Endocannabinoid receptor system.
      • Assess pros and cons of cannabinoids and their effects on the symptoms of ailments such as anxiety, chronic pain, epilepsy, gastrointestinal disorders, neurodegenerative illnesses, post-traumatic stress and migraines.
      • Understand contraindications: absolute and relative for medical practitioners.
      • Understanding medical marijuana as it relates to the continuing care of a patient.
      • Assess pros and cons of cannabinoids and their effects on the symptoms of ailments such as anxiety, chronic pain, epilepsy, gastrointestinal disorders, neurodegenerative illnesses, post-traumatic stress and migraines.
      • Evaluate the current research studies regarding opioids versus cannabinoids in the treatment of the symptoms of chronic pain.
      • Discuss side effects and contraindications of medicinal cannabis and safety concerns with its use.
      • Identify signs of abuse, misuse and chronic effects of marijuana use.
      • Drug Interactions
      • Warnings and Precautions
      • Abuse and Misuse
    • This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SynAptiv and Medical Marijuana 411. SynAptiv is accredited by the ACCME to provide continuing medical education for physicians.

      Credit Designation

      SynAptiv designates this enduring material for a maximum of 10 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      Course is available online from July 2020 through July 2021

      Estimated time to complete activity: 10 hours

      If you are a medical group or network and need multi-seat pricing, please call 844.411.0500 x814

      Disclosure Statement


      SynAptiv ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, SynAptiv identifies conflicts of interest with its instructors, planners, content managers, and other individuals who are in a position to control the content of an activity.
      The following faculty, planner and/or content manager reported the following financial relationship with commercial interests whose products or services may be mentioned in this CE activity:

      Dr. Gregory Smith
      Royalty/Patent Holder for Medical Cannabis Textbooks Consulting Fees: Callitas Therapeutics

      mm411-synaptiv-logos
      • 10 AMA PRA Category 1 Credits™
      • Instant access to all course materials
      • Printable and downloadable infographics
      • All research materials used for the online course
      • Lifetime, unlimited access
      • 24/7 access
      • No time limits
      • Start anytime
      • Work on your own time and at your own pace
      • Affordably priced

      As part of the Medical Marijuana 411 adult online education, enrollees may start and stop at any time. Any students completing our certifications and/or coursework will have a permanent student dashboard to review materials at any time. If in the future, you want to review any information, simply log-on to your dashboard to re-visit the content.

      All coursework and graphics can be downloaded for future re-use with customers, clients and patients. Additional resources of lengthier, pertinent PDFs are available by clicking on the research endnote at the end of each section module.

    • Dr. Gregory Smith

      Dr. Gregory Smith has been in primary care practice for over 30 years. He is board certified in Preventive Medicine and obtained his MPH from Harvard University. He first trained on the use of medical cannabis in 2000 in California. He has written extensively on the subject, including his popular textbook, “Medical Cannabis: Basic Science and Clinical Applications” published in 2016, and more recently “Cannabidiol, CBD: What you need to know.” And most recently in 2019, “THCV: Appetite Killer.”

      shadow
      Dr. Kevin Smith

      Dr. Kevin Smith has also been in primary care practice for over 30 years. He is board certified in Preventive Medicine and obtained his MPH from Yale University. He trained on the use of medical Cannabis several years ago and has been very active in educating physicians and other medical professionals.

      shadow

      Disclosure Statement


      SynAptiv ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, SynAptiv identifies conflicts of interest with its instructors, planners, content managers, and other individuals who are in a position to control the content of an activity.
      The following faculty, planner and/or content manager reported the following financial relationship with commercial interests whose products or services may be mentioned in this CE activity:

      Dr. Gregory Smith
      Royalty/Patent Holder for Medical Cannabis Textbooks Consulting Fees: Callitas Therapeutics

      mm411-synaptiv-logos
    • With over 800+ current, peer reviewed citations, Medical Marijuana 411 is proud to be the leader in online medical marijuana education for patients, medical professionals and dispensary consultants.

      Additional videos from leading cited experts, scientists and physicians, and downloadable graphics are part of this certification. Here is a partial list of the scientists, researchers, educators and lawyers whose work is cited within the Medical Marijuana 411 certifications.

      Our goal of creating the most current content for this cannabis certification course was obtained by using peer-reviewed research from industry experts. All citations utilized in this course meet standard guidelines and are part of the public domain. Experts listed below are not affiliated with Medical Marijuana 411 and no endorsement or authorization should be inferred by their inclusion on our website. Medical Marijuana 411 has included links to each expert to ensure credit is given for their research, legal and scientific studies under the guidelines of “Fair Use.”

      • Dr. Raphael Mechoulam
      • Dr. Sue Sisley
      • Dr. Donald Abrams
      • Dr. Jake Felice
      • Dr. Ethan Russo
      • Dr. Lester Grinspoon
      • Dr. Nishi Whiteley
      • Dr. Mark Ware
      • Dr. Yehiel Gaoni
      • Dr. Bruce Mirken
      • Charles Whitebread, Professor of Law, USC Law School
      • Neil Juneja, Gleam Law
      • Orion Inskip, Gleam Law
      • Dr. Martin Lee
      • Dr. Allyn Howlett, Ph.D
      • Dr. Gregory T Carter
      • Dr. David Bearman
      • Dr. Lumir Hanuš
      • Dr. Vincenzo Di Marzo
      • Dr. Robert Melamede
      • Dr. Dustin Sulak
      • Dr. Bonni Goldstein
      • Professor Roger Pertwee
      • Dr. Shohami
      • Dr. Ester Fride
      • Dr. Melanie Dreher

    Comments

  • 99 reviews for Utah Qualified Medical Provider Certification

    1. Yong Hui – June 7, 2020:
      5 out of 5

      More data from well done studies hopefully in the near future.

    2. Lee B. – June 1, 2020:
      5 out of 5

      very easy to navigate

    3. Michael H. – June 1, 2020:
      5 out of 5

      I think that the overall material was pretty good. I would like to perhaps some more information on possible appropriate dosing etc. In the side effects and problem section, there was no information on what was considered too much–

    4. Marcia D. – May 31, 2020:
      5 out of 5

      The content of this activity is outstanding, however is more to learn regarding the permanent side effects of chronic users; I believe we need more research on the topic to be able to fully understand the benefits of cannabinoids in the medicinal world.

    5. Faustin V. – May 31, 2020:
      5 out of 5

      A video teaching and discussing the material would be helpful

    6. Kami S. – May 31, 2020:
      5 out of 5

      It was very informational!

    7. Judith M. – May 31, 2020:
      5 out of 5

      More info than the other course I took.

    8. Adam B. – May 28, 2020:
      4 out of 5

      Great information.

    9. Jonathan W. – May 26, 2020:
      4 out of 5

      more extensive data re: benefits

    10. Ryan C. – May 23, 2020:
      4 out of 5

      I found that some of the questions were poorly worded, for example the question about the effect of cannabis on the parasympathetic nervous system. Activation/stimulation of the parasympathetic nervous system leads to the “rest and digest” effect.
      Ryan C.

    11. Mark F. – May 21, 2020:
      4 out of 5

      have information presented in recorded video

    12. Gina C. – May 21, 2020:
      5 out of 5

      Excellent education

    13. Angela G. – May 19, 2020:
      5 out of 5

      It was good

    14. Kirstin R. – May 19, 2020:
      4 out of 5

      I would like more clinical application type information – for instance, what products are available and what to recommend to patients and for how long, etc.

    15. Chris L. – May 18, 2020:
      5 out of 5

      I WOULDN’T CHANGE ANYTHING

    16. Sumer A. – May 15, 2020:
      4 out of 5

      Great information

    17. Paul R. – May 15, 2020:
      5 out of 5

      Video or audio options would have been nice.

    18. Cara M. – May 15, 2020:
      4 out of 5

      There are several spelling and grammatical errors.

    19. Todd M. – May 13, 2020:
      5 out of 5

      I thought it was great. I understand the purpose of this training but I am infuriated that that one of the expectations I am expected to follow is to prove I have first prescribed dangerous and extremely addictive opiates, which have failed, proved ineffective or have have had unacceptable and dangerous side effects and consequences before I can prescribe something much safer. It’s all a bit bassackwards. But I understand progress does not move forward in a straight line.

    20. Brandon F. – May 8, 2020:
      5 out of 5

      Very informative and concise

    21. Troy J. – May 5, 2020:
      5 out of 5

      Having an audio option would be helpful.

    22. Susan J. – May 2, 2020:
      5 out of 5

      brilliant course. Would like access to larger prints of some of the diagrams for office use

    23. Mohammad E. – May 1, 2020:
      5 out of 5

      It was great.

    24. Peter C. – April 29, 2020:
      4 out of 5

      Spell the word prostate correctly on 1 of the diagrams was spelled prostrate

    25. Julie L. – April 28, 2020:
      4 out of 5

      Some videos; or recorded interaction might be nice to break up the material instead of just reading.

    26. Renel R. – April 27, 2020:
      4 out of 5

      This activity adequately met the needs to certify as a QMP. May improve with a post-test.

    27. Brian R. – April 24, 2020:
      5 out of 5

      Videos may be helpful to people that have a visual or auditory learning style

    28. Justin W. – April 22, 2020:
      5 out of 5

      videos and audio would be good. Less reading. The reading was really good material, however.

    29. Katherine H. – April 20, 2020:
      5 out of 5

      Periodic updates on emerging research and proven indications / FDA approvals, etc. This was a great program!

    30. Max S. – April 16, 2020:
      4 out of 5

      updates on patient responses, dosing strategies

    31. John P. – April 15, 2020:
      4 out of 5

      Over all it was helpful. Could use more information on how to access CBD products and dosing parameters

    32. LeGrand B. – April 8, 2020:
      5 out of 5

      excellent information but too many unclear or intricate biochem pathways

    33. Cortnee R. – April 8, 2020:
      5 out of 5

      Very well organized, clear communication of main ideas. very relevent information. The quiz questions seemed very historical and not as relevent to patient management at times. For example: the name of the senator who supported this bill, or the year that certain provisions were incorporated.

    34. Robert J. – April 8, 2020:
      4 out of 5

      more concise

    35. Lewis J. – April 7, 2020:
      5 out of 5

      my program frooze at fist, after module 2, but Chris was super helpful at fixing the issue

    36. Scott E. – April 5, 2020:
      4 out of 5

      Overall it was a good learning activity. I hope that with more use and time that more legitimate studies can come out to support specific use.

    37. Kavita W. – April 5, 2020:
      4 out of 5

      Provide option of continuing education as more evidence becomes available.

    38. Von W. – April 5, 2020:
      3 out of 5

      The gi sections confused IBS and IBD

    39. Jason N. – April 5, 2020:
      4 out of 5

      Question wording may need correction “When CBD acts on GABA receptors, what type of effect does it have on the parasympathetic envois system?” “Calming” is coded as the correct answer, rather than activating, or stimulating. The explanation states “CBD acts on GABA receptors that direct the brain to activate the parasympathetic nervous system” (not calm it). CBD’s actions on GABA receptors calm the individual, but they activate, or stimulate the parasympathetic nervous system.

    40. Daniel C. – April 3, 2020:
      5 out of 5

      loved it

    41. Jamie L. – March 30, 2020:
      3 out of 5

      I would appreciate more specifics on benefits and side effects of types of plants such as any differences known between sativa and indica. I would like to be able to discuss these with patients more knowledgeably

    42. Brant F. – March 27, 2020:
      4 out of 5

      Overall it was a great overview of history, beneficial uses, side effects and legality.
      Could use more clarity on the process of “recommending” and dosing of medical cannabis

    43. Terri C. – March 27, 2020:
      4 out of 5

      Your specific areas of treatment were much too general and evidence conflicted with information presented. Nothing n this course convinced me that cannabis is better than current treatments.

    44. Michael C. – March 27, 2020:
      5 out of 5

      Great lectures

    45. Scott T. – March 26, 2020:
      4 out of 5

      Reasonably well done for amount and time limitations

    46. Brett P. – March 25, 2020:
      5 out of 5

      Update for 2019 studies that have been published

    47. Stephen W. – March 22, 2020:
      3 out of 5

      served its purpose for now and I will continue CME learning activities as more studies are concluded to show benefits

    48. Jennifer A. – March 17, 2020:
      5 out of 5

      It was good

    49. Jordan G. – March 15, 2020:
      5 out of 5

      really good

    50. Landon M. – March 15, 2020:
      5 out of 5

      a few spelling or grammatical errors. Videos

    51. Michael D. – March 14, 2020:
      5 out of 5

      It was a really good educational activity, I felt like the course material was relevant to practice. A little bit more on the neuroscience and future study and evidence-based information as it is available

    52. Stephen J. – March 12, 2020:
      4 out of 5

      Thank you, well organization of material with current information regarding a useful compound.

    53. Richard H. – March 11, 2020:
      5 out of 5

      Great educational activity. Very informative, practical and useful. I really enjoyed how the information was presented.

    54. Megan C. – March 8, 2020:
      4 out of 5

      I would like to be able to print all the material to have in a book for reference.

    55. Rebekah A. – March 7, 2020:
      5 out of 5

      This was very educational and helpful.

    56. Nathan C. – March 4, 2020:
      5 out of 5

      I found this to be very informative and gave me a wealth of information. Having some videos could be helpful.

    57. Gregory C. – March 4, 2020:
      5 out of 5

      need more training on dosing recommendations. Perhaps more info on the different strains and clinical differences we would see.

    58. Kamal T. – March 4, 2020:
      5 out of 5

      good info

    59. Jennifer T. – March 3, 2020:
      5 out of 5

      I thought this was adequate and relevant

    60. Geraldine S. – March 3, 2020:
      4 out of 5

      I really like how it was organized which made the information easier to navigate and understand. Content was exactly what I needed

    61. Jessinna N. – March 3, 2020:
      5 out of 5

      It was very informative, concise, and easy to navigate.

    62. Regan H. – March 3, 2020:
      5 out of 5

      I found it indormative. It could discuss ways in which the pharmacies use the medical cards and how to dose or recommend//prescribe

    63. Skylar F. – March 2, 2020:
      5 out of 5

      Some of the evaluations featured questions on nitty gritty numbers which I personally do not find too useful to know. I think clinical questions may be more useful. “A patient comes in reporting symptoms X, Y, and Z. they are this old and have these conditions. Based on the available research, what would you recommend” with multiple choice options for recommendations.

    64. Heather D. – March 2, 2020:
      4 out of 5

      Appreciate the visual learning and would like to see more data

    65. Timothy S. – March 2, 2020:
      5 out of 5

      Excellent

    66. Aaron H. – March 2, 2020:
      4 out of 5

      video presentations rather than just reading.

    67. Shannon B. – March 1, 2020:
      5 out of 5

      I would have liked to see how I provide patients with a “recommendation” note or letter.

    68. Karen B. – March 1, 2020:
      3 out of 5

      Videos would be more engaging. A

    69. Paula W. – March 1, 2020:
      4 out of 5

      We just need to continue with further reason

    70. Amber K. – March 1, 2020:
      5 out of 5

      Continuing education as more studies are conducted and more clinical information becomes available.

    71. Jason A – February 28, 2020:
      4 out of 5

      It was good.

    72. Martha S. – February 28, 2020:
      4 out of 5

      Dosing and more information on plant variety

    73. Tracy H. – February 28, 2020:
      5 out of 5

      excellent educational material

    74. Dennis H. – February 27, 2020:
      4 out of 5

      this was very informative, excellent learning format

    75. Rajiv S. – February 26, 2020:
      5 out of 5

      Getting educated on the latest trends for cannabis use and abuse is of vital importance for the patients and the medical providers and community. Thank you

    76. Steven P. – February 26, 2020:
      5 out of 5

      Great intro course

    77. Mark P. – February 26, 2020:
      4 out of 5

      Video lectures or audio to accompany text

    78. Colin M. – February 26, 2020:
      4 out of 5

      wordy slides with significant detail are nice. A summation of pertinent points afterward would be helpful.

    79. Brent E. – February 25, 2020:
      4 out of 5

      Generally good activity

    80. Sierra B. – February 25, 2020:
      5 out of 5

      great course

    81. Whitney B. – February 25, 2020:
      5 out of 5

      Great course, no changes

    82. Melissa C.L. – February 24, 2020:
      5 out of 5

      This is excellent, thank you!

    83. Stephen S. – February 24, 2020:
      4 out of 5

      Overall well done. No specific recommendations.

    84. Jared L. – February 24, 2020:
      5 out of 5

      Well organized and easy to understand. Effective format.

    85. Gary C. – February 21, 2020:
      5 out of 5

      I thought the program was well treated. Content was good, but there are a few difficult to read sections where spelling and syntax need correcting (sorry I didn’t make note of them at the time-didn’t know you were going to ask)

    86. Katrina B. – February 19, 2020:
      5 out of 5

      more specifics in regards to state legislation

    87. Glade C. – February 18, 2020:
      5 out of 5

      very helpful, good information

    88. Terry H. – February 17, 2020:
      4 out of 5

      very good, just enough detail to be helpvul

    89. Corey D. – February 16, 2020:
      5 out of 5

      well done i thought

    90. Angela T. – February 16, 2020:
      4 out of 5

      Was hoping for more clinical applications, case studies, etc. but overall was informative.
      Prostate was spelled wrong on one of the slides/PDFs
      Q8 on one of the tests, regarding parasympathetic activity is poorly written – when the PNS is stimulated, there is a calming effect in regards to autonomic function

    91. Curry W. – February 15, 2020:
      5 out of 5

      I enjoyed it quite a bit. Didn’t realize how much I “didn’t know” about cannabis.

    92. Beverly H. – February 14, 2020:
      5 out of 5

      I would love to see this presented as a lecture with a moderator or as a PowerPoint class with narrated content.

    93. James F. – February 11, 2020:
      5 out of 5

      Very educational

    94. Mandy J. – February 11, 2020:
      5 out of 5

      Noticed that if the test answer was all of the above than that was usually the right answer making the quiz a bit predictable in nature.

    95. Narith P. – February 9, 2020:
      4 out of 5

      Should be more interactive and include some videos for those that have difficulty learning through reading only.

    96. Rixt L. – January 31, 2020:
      4 out of 5

      more information about dosing, different strands of marijuana and what they accomplish, difference between edibles, film, smoking or vaping when it comes to dosing

    97. Hooton J. – January 30, 2020:
      5 out of 5

      How cannabis might be used with other treatments for depression like Ketamine.

    98. William S. – January 21, 2020:
      4 out of 5

      Thank you.

    99. Matt S. – January 14, 2020:
      5 out of 5

      More specifics on how to recommend and use THC and CBD

    Cancel reply
    Add a review

    You must be logged in to post a comment.

Related products

Details
Quick View
Cannabis 101 – Ancient Plant for Modern Illnesses Cheeba Cannabis Academy
$60.00
Add to cart Added
Details
Quick View
Pharmacist Medical Marijuana CPE
$179.00
Add to cart Added
Details
Quick View
Cannabis 101 – Ancient Plant for Modern Illnesses | Canadian Version
$75.00
Add to cart Added
Details
Quick View
Ohio State Medical Association: Continuing Medical Education
$199.00
Add to cart Added
  • Ohio State Medical Association: Continuing Medical Education
  • Washington State Medical Marijuana Consultant Renewal 10 Hour CE

Cart

Product categories

  • All Products
    • Approved U.S. States
      • Alaska
      • Massachusetts
      • Ohio
      • Utah
      • Washington
    • Books
    • Budtender Education
    • CBD
    • Certification Courses
    • CME Courses
    • CNE Courses
    • CPE Courses
    • Hemp
    • Horticulture
    • Medical Education
    • Patient Education
    • Posters
    • Psychedelics
    • Brazil
    • Canada
    • Japan
    • South Africa

Cart

No products in the cart.